STOCK TITAN

LifeMD, Inc. - LFMD STOCK NEWS

Welcome to our dedicated page for LifeMD news (Ticker: LFMD), a resource for investors and traders seeking the latest updates and insights on LifeMD stock.

LifeMD, Inc. (Nasdaq: LFMD) is a leading provider of virtual primary care, offering a comprehensive and integrated telehealth solution. The company's platform connects physicians, medical providers, pharmacists, and patients through a HIPAA-compliant system, ensuring secure AES-encrypted interactions. LifeMD provides a range of services including primary care, laboratory and pharmacy services, and specialized treatment for over 200 conditions such as men’s and women’s health, weight management, allergy & asthma, and dermatology.

LifeMD operates through two segments: Telehealth and WorkSimpli, with the majority of its revenue generated from the Telehealth segment. The company’s platform integrates electronic medical records (EMR), proprietary algorithms for case-load balancing and scheduling, customer relationship management (CRM), remote and in-home lab testing, digital prescription capabilities, and cloud pharmacy fulfillment. Additionally, LifeMD offers diagnostic telehealth equipment and sells nutritional supplements and over-the-counter products.

In 2023, LifeMD achieved significant business milestones, including the launch of a GLP-1 weight management program, which rapidly scaled to over 22,000 subscribers. The company also entered a strategic alliance with Medifast, receiving a $10 million collaboration fee and a $10 million equity investment. LifeMD continues to grow its RexMD brand, focusing on expanding telehealth products and services to increase patient lifetime value.

As of the end of 2023, LifeMD reported robust financial health with cash exceeding $30 million and a strong balance sheet. The company projects a revenue growth rate above 30% for 2024, alongside improvements in adjusted EBITDA and GAAP earnings. LifeMD remains optimistic about its strategic initiatives, including the expansion of private insurance-based programs and new offerings under its partnership with Medifast.

LifeMD is dedicated to making high-quality and affordable healthcare accessible to all, leveraging its vertically-integrated, proprietary digital care platform and a 50-state affiliated medical group. Its services are available 24/7/365, ensuring that patients can manage common medical conditions conveniently and cost-effectively.

Rhea-AI Summary
LifeMD, Inc. (Nasdaq: LFMD) reported a 23% year-over-year revenue increase to $38.6 million, with record revenues for telehealth and WorkSimpli. Adjusted EPS was $0.08 per share, compared to a loss of $0.03 in the previous year. Weight Management revenue more than quadrupled, and telehealth subscribers grew 22% to a record 207,000 patients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.89%
Tags
-
Rhea-AI Summary
LifeMD (NASDAQ: LFMD) achieved 855% revenue growth, ranking 166 on the Deloitte Technology Fast 500™. The growth is attributed to the differentiated, end-to-end care platform and affiliated medical group, supporting offerings like the LifeMD Weight Management Program.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
none
-
Rhea-AI Summary
LifeMD, Inc. will report financial results for Q3 2023 on November 8th and host a conference call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.22%
Tags
conferences earnings
Rhea-AI Summary
Joint research study by Particle Health and LifeMD demonstrates that Particle's platform can help healthcare providers contextualize patient data and identify eligibility for GLP-1 treatment, potentially saving physicians time and improving patient outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.79%
Tags
none
-
Rhea-AI Summary
LifeMD, Inc. (Nasdaq: LFMD) to participate in investor conferences in October.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.29%
Tags
conferences
-
Rhea-AI Summary
LifeMD, Inc. authorizes cash dividend of $0.5546875 per share for its 8.875% Series A Cumulative Perpetual Preferred Stock, payable on October 16, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.42%
Tags
dividends
Rhea-AI Summary
LifeMD partners with ASCEND Therapeutics to provide integrated telehealth services for EstroGel® 0.06%
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.23%
Tags
none
-
Rhea-AI Summary
LifeMD, Inc. (Nasdaq: LFMD) to participate in investor conferences in September.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.16%
Tags
conferences
-
Rhea-AI Summary
LifeMD reports record quarterly revenue of $35.9 million, up 18% YoY. Telehealth net revenues increased 11% from Q1 2023. Positive free cash flow achieved. Adjusted EBITDA increased to $1.7 million from a loss of $6.9 million in the year-ago period. Weight Management program expected to be accretive in 2024. Raised 2023 revenue guidance to $146 million to $152 million. Conference call at 4:30 p.m. Eastern time today.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.67%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.39%
Tags
conferences

FAQ

What is the current stock price of LifeMD (LFMD)?

The current stock price of LifeMD (LFMD) is $5.04 as of December 20, 2024.

What is the market cap of LifeMD (LFMD)?

The market cap of LifeMD (LFMD) is approximately 217.4M.

What services does LifeMD offer?

LifeMD offers virtual primary care, telemedicine, laboratory and pharmacy services, and specialized treatment for over 200 conditions.

What are the main revenue segments for LifeMD?

LifeMD operates through two segments: Telehealth and WorkSimpli, with the majority of its revenue generated from the Telehealth segment.

How does LifeMD ensure the security of patient interactions?

LifeMD uses a HIPAA-compliant platform with AES-encrypted interactions to ensure the security of communication between patients and healthcare providers.

What is the GLP-1 weight management program?

The GLP-1 weight management program is a medically supported weight loss service that has quickly become a leading provider in the nation, with over 22,000 subscribers as of 2023.

Who are LifeMD's strategic partners?

LifeMD has a strategic alliance with Medifast, which includes a $10 million collaboration fee and a $10 million equity investment.

How does LifeMD plan to grow in 2024?

LifeMD plans to expand its private insurance-based programs, launch new telehealth products under RexMD, and leverage its strategic partnership with Medifast to drive growth.

What is the financial outlook for LifeMD in 2024?

LifeMD expects a revenue growth rate above 30%, significant improvements in adjusted EBITDA, and GAAP earnings for 2024.

What types of telehealth equipment does LifeMD provide?

LifeMD provides custom-fabricated mobile diagnostic telehealth equipment such as cases, carts, and kiosks.

Is LifeMD's service available 24/7?

Yes, LifeMD's telehealth services are available 24/7/365, ensuring round-the-clock healthcare access for patients.

How does LifeMD integrate its telehealth services?

LifeMD's platform integrates electronic medical records, proprietary algorithms, customer relationship management, remote lab testing, digital prescriptions, and cloud pharmacy fulfillment.

LifeMD, Inc.

Nasdaq:LFMD

LFMD Rankings

LFMD Stock Data

217.41M
35.87M
15.71%
40.52%
13.55%
Health Information Services
Services-offices & Clinics of Doctors of Medicine
Link
United States of America
NEW YORK